The Health Department is offering a grant for repurposing FDA approved drugs to treat neonatal and obstetric conditions, aiming to address the challenges in developing medications for neonates and pregnant women. This grant aims to improve healthcare for these vulnerable populations by exploring new indications for existing drugs. Closing date: May 07, 2021.
Opportunity ID: 299522
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-506 |
| Funding Opportunity Title: | Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 18, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2021 |
| Current Closing Date for Applications: | May 07, 2021 |
| Archive Date: | Jun 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) State governments Special district governments Independent school districts For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Private institutions of higher education City or township governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to repurpose already FDA approved drugs for new neonatal and obstetric indications, in order to overcome the difficulties associated with the traditional development of drugs appropriate for use in neonates and pregnant women and facilitate treatment of these vulnerable populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-506.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237127 | May 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259260 | May 05, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
299522 RR_SF424_2_0-2.0.pdf
299522 PHS398_CoverPageSupplement_4_0-4.0.pdf
299522 RR_OtherProjectInfo_1_4-1.4.pdf
299522 PerformanceSite_2_0-2.0.pdf
299522 RR_KeyPersonExpanded_2_0-2.0.pdf
299522 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299522 RR_Budget_1_4-1.4.pdf
299522 RR_SubawardBudget30_1_4-1.4.pdf
299522 PHS398_ModularBudget_1_2-1.2.pdf
299522 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299522 RR_SF424_2_0-2.0.pdf
299522 PHS398_CoverPageSupplement_5_0-5.0.pdf
299522 RR_OtherProjectInfo_1_4-1.4.pdf
299522 PerformanceSite_2_0-2.0.pdf
299522 RR_KeyPersonExpanded_2_0-2.0.pdf
299522 PHS398_ResearchPlan_4_0-4.0.pdf
299522 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299522 RR_Budget_1_4-1.4.pdf
299522 RR_SubawardBudget30_1_4-1.4.pdf
299522 PHS398_ModularBudget_1_2-1.2.pdf
299522 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
